Entering text into the input field will update the search result below

Dicerna Pharmaceuticals' (DRNA) CEO Douglas Fambrough on Q4 2017 Results - Earnings Call Transcript

Mar. 08, 2018 9:55 PM ETNovo Nordisk A/S (NVO)
SA Transcripts profile picture
SA Transcripts

Dicerna Pharmaceuticals, Inc. (DRNA) Q4 2017 Earnings Conference Call March 8, 2017 4:30 PM ET


Glen Gorma – Investor Relations

Douglas Fambrough – President and Chief Executive Officer

Jack Green – Chief Financial Officer

Ralf Rosskamp – Chief Medical Officer


Umer Raffat – Evercore

Ed Arce – H.C. Wainwright


Good afternoon, ladies and gentlemen. And Welcome to the Q4 2017 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host Glen Gorma, Investor Relations. Please go ahead.

Glen Gorma

Thank you, Chris. Good afternoon and welcome to Dicerna's conference call to discuss the Company's 2017 fourth quarter and full year results.

For anyone who has not had a chance to review our results, we issued a press release after the close of market today, which is available under the investor and media tab on our website at www.Dicerna.com. You may also listen to the conference call via webcast on our website, which will be archived for 30 days beginning approximately two hours after the call has completed.

I'd like to remind listeners that management will be making forward-looking statements on the call today including, for example, expected timelines and plans for development of DCR-PHXC and other pipeline programs, expectations related to the collaboration with Boehringer Ingelheim, and guidance regarding cash usage.

Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the risk factors section of Dicerna’s latest Form 10-K filed with the SEC today. While we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so if our views change.

Now I’d like to turn the

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.